Europe Carrier Testing Services Market Size and Forecast (2021 - 2031)
The Europe Carrier Testing Services Market is projected to grow significantly, reaching an estimated US$ 610.3 million by 2031, up from US$ 212.0 million in 2024. This growth reflects a robust compound annual growth rate (CAGR) of 16.7% from 2025 to 2031.
Executive Summary and Market Analysis
The carrier testing services market in Europe is categorized into several key regions, including Germany, the UK, France, Spain, Italy, and the Rest of Europe. The evolution of carrier testing services in this region is being propelled by supportive public health systems and various government initiatives. Countries such as the UK, Germany, and France are increasingly integrating carrier screening into their standard prenatal and preconception care protocols. The presence of a well-established network of over 900 genetic counselors across Europe enhances the transition from testing to effective patient care.
Historically, parts of Europe have engaged in population screening for inherited disorders, with Mediterranean countries implementing voluntary thalassemia carrier programs for decades. Recently, even non-endemic countries have begun to adopt similar screening practices. European laboratories are progressively adopting advanced technologies, including next-generation sequencing (NGS) and bioinformatics, to provide more comprehensive and accurate carrier panels.
The regulatory and reimbursement landscapes vary significantly across different countries, necessitating that companies navigate a complex web of policies. Growth opportunities for businesses can arise from public health-led screening initiatives or private services aimed at individuals seeking genetic risk assessments prior to pregnancy. As awareness of genetic testing increases and infrastructure improves, the region is set for a steady rise in carrier testing services.
Strategic Insights
Market Segmentation Analysis
The Europe Carrier Testing Services Market can be segmented by type, medical conditions, and end users:
As the demand for comprehensive and transparent insights into genetic risks for families and healthcare providers grows, expanded carrier screening (ECS) is becoming increasingly relevant. ECS allows for the simultaneous screening of hundreds of genetic conditions, making it suitable for diverse populations. This broader approach minimizes the risk of missing hidden carriers, thereby facilitating safer reproductive planning through the availability of critical information.
For testing firms, ECS presents a unique opportunity to differentiate their services by offering high-coverage panels that are accessible and tailored to modern, diverse patient needs. The rising awareness of genetic conditions and a proactive approach to family planning are key drivers of the anticipated growth in ECS demand. Additionally, advancements in sequencing technology are reducing costs, enabling companies to offer competitive pricing for high-value testing.
ECS is fostering collaborations among fertility clinics, OB-GYN practitioners, telehealth providers, and digital health platforms, integrating screening into routine care. As ECS supports early decision-making and alleviates anxiety for prospective parents, it is increasingly recommended as part of standard preconception and prenatal care workflows. This shift towards broader and more accessible genetic testing allows companies to meet the growing consumer expectations in preventive and personalized healthcare, thereby strengthening their market position.
Country Insights
The Europe Carrier Testing Services Market is further segmented by country, including Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. The Rest of Europe accounted for the largest market share in 2024, with countries like Belgium, Russia, Luxembourg, Ukraine, Croatia, Cyprus, Romania, Slovakia, and Slovenia contributing significantly to the market.
In many European nations, genetic testing and counseling are integrated into national healthcare systems, although there are variations in regulatory frameworks and adoption rates. While genetic counselors are present in many countries, in some regions, the role is still primarily held by physicians. Carrier screening programs for disorders such as thalassemia, spinal muscular atrophy, and cystic fibrosis are often led by medical genetics departments or small public health initiatives. The adoption of NGS-based panels is on the rise, driven by cross-border collaborations and private sector investments.
The European market presents a diverse landscape for companies to penetrate through clinical genetics collaborations, partnerships with fertility clinics, and specialized laboratories. However, businesses must navigate country-specific regulations, infrastructure maturity, and reimbursement complexities.
Company Profiles
Key players in the Europe Carrier Testing Services Market include F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Eurofins Scientific SE, Myriad Genetics Inc, Laboratory Corp of America Holdings, MedGenome Inc, Gene By Gene Ltd, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc, and Illumina, Inc. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products to consumers.
Executive Summary and Market Analysis
The carrier testing services market in Europe is categorized into several key regions, including Germany, the UK, France, Spain, Italy, and the Rest of Europe. The evolution of carrier testing services in this region is being propelled by supportive public health systems and various government initiatives. Countries such as the UK, Germany, and France are increasingly integrating carrier screening into their standard prenatal and preconception care protocols. The presence of a well-established network of over 900 genetic counselors across Europe enhances the transition from testing to effective patient care.
Historically, parts of Europe have engaged in population screening for inherited disorders, with Mediterranean countries implementing voluntary thalassemia carrier programs for decades. Recently, even non-endemic countries have begun to adopt similar screening practices. European laboratories are progressively adopting advanced technologies, including next-generation sequencing (NGS) and bioinformatics, to provide more comprehensive and accurate carrier panels.
The regulatory and reimbursement landscapes vary significantly across different countries, necessitating that companies navigate a complex web of policies. Growth opportunities for businesses can arise from public health-led screening initiatives or private services aimed at individuals seeking genetic risk assessments prior to pregnancy. As awareness of genetic testing increases and infrastructure improves, the region is set for a steady rise in carrier testing services.
Strategic Insights
Market Segmentation Analysis
The Europe Carrier Testing Services Market can be segmented by type, medical conditions, and end users:
- By Type: The market is divided into Expanded Carrier Screening (ECS) and Targeted Disease Carrier Screening. The ECS segment is expected to dominate the market in 2024 due to its ability to screen for multiple conditions simultaneously.
- By Medical Conditions: The market is categorized into Pulmonary Conditions, Hematological Conditions, Neurological Conditions, and Other Medical Conditions. The Pulmonary Conditions segment is anticipated to lead the market in 2024.
- By End User: The market is segmented into Hospital-Based Laboratories, Diagnostic Laboratories, and Other End Users, with Hospital-Based Laboratories expected to hold the largest share in 2024.
As the demand for comprehensive and transparent insights into genetic risks for families and healthcare providers grows, expanded carrier screening (ECS) is becoming increasingly relevant. ECS allows for the simultaneous screening of hundreds of genetic conditions, making it suitable for diverse populations. This broader approach minimizes the risk of missing hidden carriers, thereby facilitating safer reproductive planning through the availability of critical information.
For testing firms, ECS presents a unique opportunity to differentiate their services by offering high-coverage panels that are accessible and tailored to modern, diverse patient needs. The rising awareness of genetic conditions and a proactive approach to family planning are key drivers of the anticipated growth in ECS demand. Additionally, advancements in sequencing technology are reducing costs, enabling companies to offer competitive pricing for high-value testing.
ECS is fostering collaborations among fertility clinics, OB-GYN practitioners, telehealth providers, and digital health platforms, integrating screening into routine care. As ECS supports early decision-making and alleviates anxiety for prospective parents, it is increasingly recommended as part of standard preconception and prenatal care workflows. This shift towards broader and more accessible genetic testing allows companies to meet the growing consumer expectations in preventive and personalized healthcare, thereby strengthening their market position.
Country Insights
The Europe Carrier Testing Services Market is further segmented by country, including Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. The Rest of Europe accounted for the largest market share in 2024, with countries like Belgium, Russia, Luxembourg, Ukraine, Croatia, Cyprus, Romania, Slovakia, and Slovenia contributing significantly to the market.
In many European nations, genetic testing and counseling are integrated into national healthcare systems, although there are variations in regulatory frameworks and adoption rates. While genetic counselors are present in many countries, in some regions, the role is still primarily held by physicians. Carrier screening programs for disorders such as thalassemia, spinal muscular atrophy, and cystic fibrosis are often led by medical genetics departments or small public health initiatives. The adoption of NGS-based panels is on the rise, driven by cross-border collaborations and private sector investments.
The European market presents a diverse landscape for companies to penetrate through clinical genetics collaborations, partnerships with fertility clinics, and specialized laboratories. However, businesses must navigate country-specific regulations, infrastructure maturity, and reimbursement complexities.
Company Profiles
Key players in the Europe Carrier Testing Services Market include F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Eurofins Scientific SE, Myriad Genetics Inc, Laboratory Corp of America Holdings, MedGenome Inc, Gene By Gene Ltd, Thermo Fisher Scientific Inc., Fulgent Genetics, Inc, and Illumina, Inc. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products to consumers.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. CARRIER TESTING SERVICES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. EUROPE CARRIER TESTING SERVICES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. CARRIER TESTING SERVICES MARKET - EUROPE MARKET ANALYSIS
6.1 Europe Carrier Testing Services Market Revenue (US$ Million), 2024 - 2031
6.2 Europe Carrier Testing Services Market Forecast and Analysis
7. EUROPE CARRIER TESTING SERVICES MARKET REVENUE ANALYSIS - BY TYPE
7.1 Expanded Carrier Screening
7.1.1 Overview
7.1.2 Expanded Carrier Screening: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Targeted Disease Carrier Screening
7.2.1 Overview
7.2.2 Targeted Disease Carrier Screening: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. EUROPE CARRIER TESTING SERVICES MARKET REVENUE ANALYSIS - BY MEDICAL CONDITIONS
8.1 Pulmonary Conditions
8.1.1 Overview
8.1.2 Pulmonary Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Hematological Conditions
8.2.1 Overview
8.2.2 Hematological Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Neurological Conditions
8.3.1 Overview
8.3.2 Neurological Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Other Medical Conditions
8.4.1 Overview
8.4.2 Other Medical Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. EUROPE CARRIER TESTING SERVICES MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospital-Based Laboratories
9.1.1 Overview
9.1.2 Hospital-Based Laboratories: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Diagnostic Laboratories
9.2.1 Overview
9.2.2 Diagnostic Laboratories: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Other End Users
9.3.1 Overview
9.3.2 Other End Users: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. EUROPE CARRIER TESTING SERVICES MARKET - COUNTRY ANALYSIS
10.1 Europe
10.1.1 Europe Carrier Testing Services Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Europe Carrier Testing Services Market Revenue and Forecast and Analysis - by Country
10.1.2.2 Germany: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 Germany: Europe Carrier Testing Services Market Share - by Type
10.1.2.2.2 Germany: Europe Carrier Testing Services Market Share - by Medical Conditions
10.1.2.2.3 Germany: Europe Carrier Testing Services Market Share - by End User
10.2.3.3 United Kingdom: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 United Kingdom: Europe Carrier Testing Services Market Share - by Type
10.2.3.3.2 United Kingdom: Europe Carrier Testing Services Market Share - by Medical Conditions
10.2.3.3.3 United Kingdom: Europe Carrier Testing Services Market Share - by End User
10.3.4.4 France: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 France: Europe Carrier Testing Services Market Share - by Type
10.3.4.4.2 France: Europe Carrier Testing Services Market Share - by Medical Conditions
10.3.4.4.3 France: Europe Carrier Testing Services Market Share - by End User
10.4.5.5 Italy: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Italy: Europe Carrier Testing Services Market Share - by Type
10.4.5.5.2 Italy: Europe Carrier Testing Services Market Share - by Medical Conditions
10.4.5.5.3 Italy: Europe Carrier Testing Services Market Share - by End User
10.5.6.6 Spain: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5.6.6.1 Spain: Europe Carrier Testing Services Market Share - by Type
10.5.6.6.2 Spain: Europe Carrier Testing Services Market Share - by Medical Conditions
10.5.6.6.3 Spain: Europe Carrier Testing Services Market Share - by End User
10.6.7.7 Rest of Europe: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6.7.7.1 Rest of Europe: Europe Carrier Testing Services Market Share - by Type
10.6.7.7.2 Rest of Europe: Europe Carrier Testing Services Market Share - by Medical Conditions
10.6.7.7.3 Rest of Europe: Europe Carrier Testing Services Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Quest Diagnostics Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Eurofins Scientific SE
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Myriad Genetics Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Laboratory Corp of America Holdings
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 MedGenome Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Gene By Gene Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Thermo Fisher Scientific Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Fulgent Genetics, Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Illumina, Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. CARRIER TESTING SERVICES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. EUROPE CARRIER TESTING SERVICES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. CARRIER TESTING SERVICES MARKET - EUROPE MARKET ANALYSIS
6.1 Europe Carrier Testing Services Market Revenue (US$ Million), 2024 - 2031
6.2 Europe Carrier Testing Services Market Forecast and Analysis
7. EUROPE CARRIER TESTING SERVICES MARKET REVENUE ANALYSIS - BY TYPE
7.1 Expanded Carrier Screening
7.1.1 Overview
7.1.2 Expanded Carrier Screening: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Targeted Disease Carrier Screening
7.2.1 Overview
7.2.2 Targeted Disease Carrier Screening: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. EUROPE CARRIER TESTING SERVICES MARKET REVENUE ANALYSIS - BY MEDICAL CONDITIONS
8.1 Pulmonary Conditions
8.1.1 Overview
8.1.2 Pulmonary Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Hematological Conditions
8.2.1 Overview
8.2.2 Hematological Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Neurological Conditions
8.3.1 Overview
8.3.2 Neurological Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Other Medical Conditions
8.4.1 Overview
8.4.2 Other Medical Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. EUROPE CARRIER TESTING SERVICES MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospital-Based Laboratories
9.1.1 Overview
9.1.2 Hospital-Based Laboratories: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Diagnostic Laboratories
9.2.1 Overview
9.2.2 Diagnostic Laboratories: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Other End Users
9.3.1 Overview
9.3.2 Other End Users: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. EUROPE CARRIER TESTING SERVICES MARKET - COUNTRY ANALYSIS
10.1 Europe
10.1.1 Europe Carrier Testing Services Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Europe Carrier Testing Services Market Revenue and Forecast and Analysis - by Country
10.1.2.2 Germany: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 Germany: Europe Carrier Testing Services Market Share - by Type
10.1.2.2.2 Germany: Europe Carrier Testing Services Market Share - by Medical Conditions
10.1.2.2.3 Germany: Europe Carrier Testing Services Market Share - by End User
10.2.3.3 United Kingdom: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 United Kingdom: Europe Carrier Testing Services Market Share - by Type
10.2.3.3.2 United Kingdom: Europe Carrier Testing Services Market Share - by Medical Conditions
10.2.3.3.3 United Kingdom: Europe Carrier Testing Services Market Share - by End User
10.3.4.4 France: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 France: Europe Carrier Testing Services Market Share - by Type
10.3.4.4.2 France: Europe Carrier Testing Services Market Share - by Medical Conditions
10.3.4.4.3 France: Europe Carrier Testing Services Market Share - by End User
10.4.5.5 Italy: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Italy: Europe Carrier Testing Services Market Share - by Type
10.4.5.5.2 Italy: Europe Carrier Testing Services Market Share - by Medical Conditions
10.4.5.5.3 Italy: Europe Carrier Testing Services Market Share - by End User
10.5.6.6 Spain: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5.6.6.1 Spain: Europe Carrier Testing Services Market Share - by Type
10.5.6.6.2 Spain: Europe Carrier Testing Services Market Share - by Medical Conditions
10.5.6.6.3 Spain: Europe Carrier Testing Services Market Share - by End User
10.6.7.7 Rest of Europe: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6.7.7.1 Rest of Europe: Europe Carrier Testing Services Market Share - by Type
10.6.7.7.2 Rest of Europe: Europe Carrier Testing Services Market Share - by Medical Conditions
10.6.7.7.3 Rest of Europe: Europe Carrier Testing Services Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Quest Diagnostics Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Eurofins Scientific SE
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Myriad Genetics Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Laboratory Corp of America Holdings
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 MedGenome Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Gene By Gene Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Thermo Fisher Scientific Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Fulgent Genetics, Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Illumina, Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
LIST OF TABLES
Table 1. Europe Carrier Testing Services Market Segmentation
Table 2. List of Vendors
Table 3. Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 5. Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 6. Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. Germany: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 9. Germany: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 10. Germany: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. United Kingdom: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 12. United Kingdom: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 13. United Kingdom: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. France: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 15. France: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 16. France: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Italy: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 18. Italy: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 19. Italy: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Spain: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 21. Spain: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 22. Spain: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 23. Rest of Europe: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 24. Rest of Europe: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 25. Rest of Europe: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 26. Heat Map Analysis by Key Players
Table 1. Europe Carrier Testing Services Market Segmentation
Table 2. List of Vendors
Table 3. Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 5. Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 6. Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. Germany: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 9. Germany: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 10. Germany: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. United Kingdom: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 12. United Kingdom: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 13. United Kingdom: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. France: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 15. France: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 16. France: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Italy: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 18. Italy: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 19. Italy: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Spain: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 21. Spain: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 22. Spain: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 23. Rest of Europe: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 24. Rest of Europe: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Medical Conditions
Table 25. Rest of Europe: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 26. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Europe Carrier Testing Services Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Carrier Testing Services Market
Figure 4. Europe Carrier Testing Services Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Carrier Testing Services Market Revenue (US$ Million), 2024 - 2031
Figure 7. Europe Carrier Testing Services Market Share (%) - by Type, 2024 and 2031
Figure 8. Expanded Carrier Screening: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Targeted Disease Carrier Screening: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Europe Carrier Testing Services Market Share (%) - by Medical Conditions, 2024 and 2031
Figure 11. Pulmonary Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Hematological Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Neurological Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Other Medical Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Europe Carrier Testing Services Market Share (%) - by End User, 2024 and 2031
Figure 16. Hospital-Based Laboratories: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Diagnostic Laboratories: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Other End Users: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Europe Carrier Testing Services Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 20. Germany: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. United Kingdom: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. France: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Italy: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Spain: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Rest of Europe: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Company Positioning & Concentration
Figure 1. Europe Carrier Testing Services Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Carrier Testing Services Market
Figure 4. Europe Carrier Testing Services Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Carrier Testing Services Market Revenue (US$ Million), 2024 - 2031
Figure 7. Europe Carrier Testing Services Market Share (%) - by Type, 2024 and 2031
Figure 8. Expanded Carrier Screening: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Targeted Disease Carrier Screening: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Europe Carrier Testing Services Market Share (%) - by Medical Conditions, 2024 and 2031
Figure 11. Pulmonary Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Hematological Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Neurological Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Other Medical Conditions: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Europe Carrier Testing Services Market Share (%) - by End User, 2024 and 2031
Figure 16. Hospital-Based Laboratories: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Diagnostic Laboratories: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Other End Users: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Europe Carrier Testing Services Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 20. Germany: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. United Kingdom: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. France: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Italy: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Spain: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Rest of Europe: Europe Carrier Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Company Positioning & Concentration
